Invasive mold infection in heart transplant recipients: A nationwide multicenter matched case-control study between

Baptiste Hoellinger1, Eric Epailly2, Fanny Vuotto3

  • 1Centre Hospitalier Universitaire de Strasbourg, Services de Maladies Infectieuses et Tropicales, Université de Strasbourg, Strasbourg, France.

Insights

Invasive mold infections (IMI) are serious after heart transplants. Older age, longer ICU stays, and surgical revisions increase IMI risk. Early identification of high-risk patients is crucial for better outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Invasive mold infections (IMI) are rare but severe complications following heart transplantation.
  • Risk factors and outcomes for IMI in heart transplant recipients require updated understanding.

Purpose of the Study:

  • To update the risk factors and outcomes associated with invasive mold infections (IMI) in heart transplant recipients.
  • To identify predictors of 90-day mortality in this patient population.

Main Methods:

  • A multicenter case-control study conducted across 14 French centers from 2008 to 2022.
  • 120 cases of probable or proven IMI were matched with 120 control patients.
  • Conditional logistic regression and Cox regression were used to identify risk factors and mortality predictors.

Main Results:

  • The 1-year incidence of IMI was 3.1%, with a median onset of 121 days post-transplant.
  • Independent risk factors for IMI included age >60 years, prolonged ICU stay (>15 days), and surgical revision.
  • Hemodialysis and disseminated infection predicted 90-day mortality in infected patients.

Conclusions:

  • Age, ICU stay duration, and surgical revisions are key risk factors for IMI post-heart transplant.
  • Hemodialysis and infection dissemination significantly impact short-term survival.
  • These findings can aid in identifying high-risk individuals and inform prophylaxis strategies.

Related Concept Videos

Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
411
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
470
Wilcoxon Signed-Ranks Test for Matched Pairs01:09

Wilcoxon Signed-Ranks Test for Matched Pairs

The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
495
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.8K
Anatomy of the Heart01:20

Anatomy of the Heart

The heart is a hollow, muscular organ approximately the size of a fist, consisting of four chambers. It is enclosed in the pericardium, a fibrous sac with two layers: the visceral and parietal pericardium, separated by a fluid-filled space containing serous fluid to reduce friction.
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
3.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
586